FDA advisory panel recommends use of Merck's COVID-19 pill
The Food and Drug Administration's Antimicrobial Drugs Advisory Committee voted on Tuesday to recommend emergency authorization of molnupiravir, Merck's oral COVID-19 treatment pill.
It was a narrow vote of 13-10, and some panel members said that after they weighed the risks and benefits, they felt there were still too many unanswered questions about the pill's safety and whether it could enable the virus to mutate into variants that can get around current vaccines, CNBC reports.
Dr. Michael Green, a pediatric transplant specialist at the University of Pittsburgh School of Medicine Division of Infectious Diseases, voted in favor of the drug, and said he supported emergency authorization because there aren't many therapies for high-risk individuals with COVID-19. Still, it was "a very difficult decision," Green said, and he recommends that the pill only be used by unvaccinated people at most risk of severe COVID-19.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Molnupiravir is an antiviral drug that is designed to treat adults with mild to moderate COVID-19 symptoms who are at high risk of severe illness. It would be given to patients at home, in the form of an 800 milligram pill taken every 12 hours for five days following the start of symptoms. On Tuesday, Merck presented new data to the FDA showing that the drug was 30 percent effective in preventing hospitalizations and death from COVID-19. The company also said the drug should not be given to children and pregnant women.
Before the public can use the drug on an emergency basis, final authorization has to come from the FDA and the Centers for Disease Control and Prevention; typically, the FDA follows along with the Antimicrobial Drugs Advisory Committee's recommendations.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Ottawa climate talks: can global plastic problem be solved?
In the spotlight Nations aim to draft world's first treaty on plastic pollution, but resistance from oil- and gas-producing countries could limit scope
By Harriet Marsden, The Week UK Published
-
Netherlands split on WFH for sex workers
Speed Read Councils concerned over 'nuisance' of at-home sex work, but others say changes will curb underground sex trade
By Arion McNicoll, The Week UK Published
-
'He adored Trump, and then rejected him'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published